Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Patient Talk Podcast: Future management of the pandemic through existing and new assays

Article-Patient Talk Podcast: Future management of the pandemic through existing and new assays

Dr James Donnelly, Technical Director, National Reference Laboratory, UAE, sheds light on the latest testing methods.

In 2020 the UAE became the first country worldwide in which the number of Covid-19 tests exceeded the population count, with local health authorities performing in excess of 10 million tests.  

Mubadala Healthcare's National Reference Laboratory (NRL), focused on increasing the quality, spectrum, coverage and efficiency of lab testing in the UAE and region, last year introduced an advanced virus-detection system and adopted new technology for delivering test results in record time.

In this last Patient Talk episode, we chat with Dr James G Donnelly, Technical Director at National Reference Laboratory (NRL), to uncover more about how NRL responded to the pandemic, and how they are innovating.   

Dr Donnelly is an expert in laboratory operations with experience in academic, corporate, and clinical laboratory settings.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.